Tislelizumab

Index terms

Tislelizumab

Sibling codes

XM0550 – Amivantamab
XM0AN7 – Oportuzumab monatox
XM2KA7 – Retifanlimab
XM5Q93 – Sacituzumab govitecan

Foundation entity

Tislelizumab – http://id.who.int/icd/entity/1367590920

Part of: XM9ND9: Programmed cell death protein 1/death ligand 1 inhibitors › XM1JG6: Monoclonal antibodies and antibody drug conjugates › XM6WT8: Agents primarily affecting blood constituents or immune system › XM6S30: Medicaments › X: Extension Codes